Clarametyx 2022-05: Immunogenicity assessment of a peptide immunogen in naive mice - adjuvant screening

Project Details

StatusFinished
Effective start/end date21/02/2220/02/23

Funding

  • Clarametyx Biosciences, Inc.: $8,941.00